Related references
Note: Only part of the references are listed.
Article
Biotechnology & Applied Microbiology
Aine O'Toole et al.
Summary: The study investigates how SARS-CoV-2 Pango lineages can be reliably designated using spike-only nucleotide sequences. While many lineages can be identified clearly with spike-only sequences, some sequences are shared among multiple lineages. The concept of lineage-sets is introduced to represent the range of Pango lineages consistent with observed mutations in spike sequences, providing a foundation for software tools to assign newly-generated sequences to lineage sets.
Article
Infectious Diseases
Carlos A. Prete et al.
Summary: This study used serial blood samples from repeat blood donors to estimate reinfection rates caused by the Gamma variant during the second wave in Manaus, Brazil. The study found that 13.6% of all presumed Gamma infections in 2021 were reinfections, increasing to 22.7% and 39.3% when probable and possible reinfections were included. Previous infection provided a protection rate of 85.3%, decreasing to 72.5% and 39.5% when probable and possible reinfections were included.
BMC INFECTIOUS DISEASES
(2022)
Letter
Cell Biology
Pengfei Li et al.
Review
Medical Laboratory Technology
Marco Ciotti et al.
Summary: The article discusses the development of COVID-19 vaccines, the impact of viral variants on transmission and virus antibodies, and methods for measuring vaccine antibody responses. It also emphasizes the importance of using the WHO International Standard to accurately calibrate immunoassays.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
(2022)
Editorial Material
Immunology
Vivek P. Chavda et al.
EXPERT REVIEW OF VACCINES
(2022)
Review
Immunology
Vivek P. Chavda et al.
Summary: This article provides a comprehensive overview of SARS-CoV-2 and COVID-19, including viral transmission and subsequent events in the human body. It also presents different drugs and vaccines used for the management of COVID-19. Several natural drugs are proposed for COVID-19 management, and an overview of post-COVID-19 complications in recovered patients is also provided.
Article
Infectious Diseases
Ngoc-Niem Bui et al.
Summary: This study characterized the haplotype and sub-haplotype diversity of SARS-CoV-2 global variants and analyzed the distribution of sub-haplotypes in groups with low and high COVID-19 vaccination rates. The results showed the dominance of certain variants and the emergence of new sub-haplotypes, highlighting the impact of vaccination strategies on viral mutations and transmission.
INFECTION GENETICS AND EVOLUTION
(2022)
Editorial Material
Infectious Diseases
Eskild Petersen et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2022)
Editorial Material
Medicine, General & Internal
Anna Wald
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2022)
Article
Virology
Shailendra K. Saxena et al.
Summary: This study investigates the transmission dynamics and mutational prevalence of the novel SARS-CoV-2 Omicron variant. The findings show that Omicron has been reported in various countries and exhibits distinct differences from other prevalent VOCs. The spike glycoprotein of Omicron displays critical amino acid changes. This study contributes to the understanding of the transmission and mutation mechanisms of Omicron.
JOURNAL OF MEDICAL VIROLOGY
(2022)
News Item
Infectious Diseases
Talha Burki
Summary: The narrative about SARS-CoV-2 variants of concern in people living with HIV, spread by the media, is not comprehensive.
LANCET INFECTIOUS DISEASES
(2022)
Article
Infectious Diseases
William S. Hart et al.
Summary: The study found that the Delta variant transmits more quickly within households compared to the Alpha variant, likely due to rapid depletion of susceptible individuals and a possible decrease in the generation time.
LANCET INFECTIOUS DISEASES
(2022)
Editorial Material
Geriatrics & Gerontology
Vivek P. Chavda et al.
Review
Immunology
Paul Moss
Summary: T cell immunity plays a central role in controlling SARS-CoV-2 infection, with early responses correlating with protection. T cell memory provides broad recognition of viral proteins, limiting the impact of viral variants and offering protection against severe disease. Current COVID-19 vaccines elicit robust T cell responses, contributing to the prevention of hospitalization or death. Therefore, the importance of T cell immunity may have been underestimated.
Letter
Medicine, General & Internal
Shirley Collie et al.
Summary: Preliminary data from a test-negative study design in South Africa showed that two doses of the BNT162b2 vaccine had an efficacy of 50 to 70% against hospitalization caused by the omicron variant in Gauteng province.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Article
Medicine, General & Internal
David W. Eyre et al.
Summary: In this study, it was found that vaccination reduces the transmission risk of the Delta variant, but the protection of the vaccine decreases over time. The effectiveness of the vaccine is higher against the Alpha variant compared to the Delta variant.
NEW ENGLAND JOURNAL OF MEDICINE
(2022)
Letter
Immunology
Pragya D. Yadav et al.
CLINICAL INFECTIOUS DISEASES
(2022)
Review
Pharmacology & Pharmacy
Rong-Ping Chen et al.
Summary: Transdermal drug delivery is a safe and effective method of administering drugs through the skin. Transferosomes, flexible vesicles with better skin penetration properties, have been discovered as a promising carrier for transdermal drug delivery. By attaching specific herbal extracts to phosphatidylcholine, phytosomes (Transferosomes) improve drug solubility and absorption. This review highlights the potential of nanotechnology, particularly phytosomes, as lipid-based nanocarriers for transdermal drug delivery.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Public, Environmental & Occupational Health
Pragya D. Yadav et al.
Summary: This study collected samples from travelers and found that SARS-CoV-2 variants are more easily transmitted through international travel. The researchers successfully isolated two strains with high viral RNA loads, which is important for evaluating the protective efficacy of current and upcoming COVID-19 vaccines in India.
JOURNAL OF INFECTION AND PUBLIC HEALTH
(2022)
Review
Medicine, General & Internal
Shi-Yan Ren et al.
Summary: This review summarizes the highly mutated regions, infectivity, transmission, vaccine breakthrough, and antibody resistance of the SARS-CoV-2 variant Omicron. Omicron is highly transmissible and may cause milder symptoms. Vaccines are less effective against the Omicron variant.
WORLD JOURNAL OF CLINICAL CASES
(2022)
Letter
Infectious Diseases
Yingying Lu et al.
Review
Respiratory System
Joao Gaspar-Marques et al.
Summary: This paper reviews the research on severe asthma and COVID-19, and summarizes the disease mechanisms of COVID-19 and the relationship between severe asthma endotypes and COVID-19. The results suggest that type2-high may have a protective role in infection risk and disease course, and there is conflicting data regarding the epidemiological relationship between severe asthma patients and COVID-19. Furthermore, the use of biologics for severe asthma does not seem to increase the risk of infection and severe COVID-19.
Review
Environmental Sciences
Rekha Khandia et al.
Summary: Since December 2019, SARS-CoV-2 has been rapidly evolving and mutating, leading to various variants with different levels of infectivity and lethality. The most recent variant of concern is Omicron (B.1.1.529), which has raised concerns about its ability to evade pre-existing immunity and overcome antibody-based therapies. Several theories have been proposed to explain the high number of mutations in Omicron. To successfully handle the ongoing pandemic, a multifaceted approach including rapid diagnosis, genome analysis, vaccination, and updated medical facilities is needed.
ENVIRONMENTAL RESEARCH
(2022)
Article
Infectious Diseases
Katherine A. Twohig et al.
Summary: A study in England found that patients with COVID-19 infected with the delta variant were more likely to be admitted to hospital or attend emergency care compared to those infected with the alpha variant. This suggests that outbreaks of the delta variant in unvaccinated populations may pose a greater burden on healthcare services.
LANCET INFECTIOUS DISEASES
(2022)
Review
Virology
Chiranjib Chakraborty et al.
Summary: The study discusses the emergence of alarming SARS-CoV-2 variants globally, highlighting key properties, mutations, and clinical characteristics of both variant of concern (VOC) and variant of interest (VOI) variants. The comprehensive review offers updated information on these newly appearing variants to aid researchers in formulating strategies to control the COVID-19 pandemic.
REVIEWS IN MEDICAL VIROLOGY
(2022)
Article
Immunology
Vivek P. Chavda et al.
Summary: The Omicron variant of SARS-CoV-2 is spreading in communities where previous infections and vaccinations have taken place. Over 130 countries have implemented booster dose programs to combat the Omicron variant. While early findings suggest that booster doses may enhance protection against Omicron, further research is needed to determine the efficacy of vaccines. This short communication critically discusses research findings on the booster dose strategy for Omicron.
Letter
Biochemistry & Molecular Biology
Xiaohong Du et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY
(2022)
Article
Genetics & Heredity
Ankur Das et al.
Summary: COVID-19 is a severe acute respiratory disease caused by SARS-CoV-2, researchers have identified the basic biology of the virus, including its genome structure and expression information, and various prevention strategies have been implemented globally.
Editorial Material
Medicine, General & Internal
Adam S. Lauring et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
News Item
Medicine, General & Internal
Rita Rubin
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Review
Pharmacology & Pharmacy
Sylwester Drozdzal et al.
Summary: The COVID-19 pandemic poses a significant threat to global health with various therapeutic agents initially proclaimed to be effective, but later disproved. The Pfizer agent PAXLOVIDTM has shown promising results in reducing hospitalization time and death rates. Further development of additional treatments is needed due to the insufficiency of current recommended therapeutic options.
DRUG RESISTANCE UPDATES
(2021)
Article
Immunology
Vivek P. Chavda et al.
Summary: DNA vaccines have the potential to provide protection against SARS-CoV-2 by transforming host cells into protein factories that trigger the immune system to produce antibodies. This vaccine platform offers advantages such as strong cellular immune response, high safety margin, and simple production process, making it a robust choice for large-scale production.
EXPERT REVIEW OF VACCINES
(2021)
Article
Biochemistry & Molecular Biology
Jerome H. Kim et al.
Summary: Following the announcement of COVID-19 vaccine efficacy in clinical trials, a comprehensive strategy is needed for global vaccination, including manufacturing, support, supply coordination, equitable distribution, and logistics. Additionally, addressing scientific questions to improve vaccine efficacy is crucial for ending the pandemic effectively and efficiently.
Article
Medicine, General & Internal
J. Sadoff et al.
Summary: The study conducted a multicenter, placebo-controlled, phase 1-2a trial, with participants randomly assigned to receive the Ad26.COV2.S vaccine. The results showed that the safety and immunogenicity profiles of the vaccine support further development.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Infectious Diseases
Carolina Kymie Vasques Nonaka et al.
Summary: The study found that there was a decrease in the median age of ICU patients from 66 to 58 years between June 2020 and February 2021, with an increased proportion of patients without comorbidities. The second wave showed a significant reduction in the cycle threshold values of SARS-CoV-2 RT-PCR tests.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Immunology
Saathvik R. Kannan et al.
Summary: The study revealed differences in the mutational profile between Delta and Delta Plus variants, with Delta Plus having more high-prevalence mutations and unique signature mutations. Structural analysis showed that these mutations can weaken the interactions between the virus and antibodies.
JOURNAL OF AUTOIMMUNITY
(2021)
Article
Biochemistry & Molecular Biology
Wilfredo F. Garcia-Beltran et al.
Summary: New variants of SARS-CoV-2 show high resistance to vaccine neutralization, with some able to escape vaccine responses with just a few mutations, highlighting the importance of developing broadly protective measures against variants.
Article
Biochemistry & Molecular Biology
Daming Zhou et al.
Summary: The race to develop vaccines against SARS-CoV-2 variants, such as B.1.1.7, B.1.351, and P.1, is ongoing as these variants have mutations in the spike protein, potentially leading to immune escape. A structure-function analysis of B.1.351 revealed tighter ACE2 binding and widespread evasion from monoclonal antibody neutralization, particularly driven by the E484K mutation.
Article
Microbiology
Allison J. Greaney et al.
Summary: The evolution of SARS-CoV-2 may impact the recognition of the virus by human antibody-mediated immunity, with mutations affecting antibody binding varying significantly among individuals and within the same individual over time. Despite this variability, mutations that greatly reduce antibody binding usually occur at specific sites in the RBD, with E484 being the most crucial. These findings can inform surveillance efforts for SARS-CoV-2 evolution in the future.
CELL HOST & MICROBE
(2021)
Letter
Infectious Diseases
Vimvara Vacharathit et al.
LANCET INFECTIOUS DISEASES
(2021)
Review
Biochemistry & Molecular Biology
Ramandeep Singh et al.
Summary: The COVID-19 pandemic has posed the most challenging global health crisis in a century, infecting more than 100 million people and causing over 2.15 million deaths. Rapid efforts have been made to develop vaccines to combat the virus and prevent further spread.
Editorial Material
Medicine, General & Internal
John P. Moore et al.
Summary: This article reviews the circulating SARS-CoV-2 genetic variants and the mechanisms of immunity by which they may escape vaccine-induced protection, proposing 6 measures to address these issues, including enhanced variant isolation and testing procedures, and continued adherence to mask-wearing and other established public health measures.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Letter
Medicine, General & Internal
A. Sarah Walker et al.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Letter
Infectious Diseases
Oliver T. R. Toovey et al.
JOURNAL OF INFECTION
(2021)
Review
Infectious Diseases
Susanne H. Hodgson et al.
Summary: The development of a vaccine for the novel coronavirus is crucial to prevent the spread of the pandemic and reduce disease mortality. The efficacy endpoint is protection against severe disease and death, but evaluating this in phase 3 clinical trials poses challenges.
LANCET INFECTIOUS DISEASES
(2021)
Article
Multidisciplinary Sciences
Zijun Wang et al.
Summary: Volunteers who received the Moderna or Pfizer-BioNTech vaccine showed high levels of antibodies and memory B cell responses against SARS-CoV-2, with activity similar to individuals who had recovered from natural infection. However, their efficacy against specific SARS-CoV-2 variants was reduced, indicating a potential need for periodic updates to mRNA vaccines to maintain clinical efficacy.
Article
Green & Sustainable Science & Technology
Jiri Jaromir Klemes et al.
Summary: This paper discusses the energy and environmental impacts of vaccinations, emphasizing the importance of implementing vaccinations in a maximum sustainable way. The cold supply chain accounts for a significant portion of the energy consumption in the vaccine lifecycle, highlighting the need for a sustainable supply chain model. This effort plays a critical role in preparing for future pandemics and suggests exploring sustainable materials to mitigate environmental footprints.
RENEWABLE & SUSTAINABLE ENERGY REVIEWS
(2021)
Editorial Material
Medicine, General & Internal
Kamala Thiagarajan
BMJ-BRITISH MEDICAL JOURNAL
(2021)
Article
Environmental Sciences
Malik Sallam et al.
Summary: The study aimed to evaluate COVID-19 vaccine acceptance among university students in Jordan and found an association between vaccine conspiracy beliefs and vaccine hesitancy.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2021)
Review
Immunology
Kelvin Kai-Wang To et al.
Summary: The lack of modern medical management and vaccines could lead to the COVID-19 pandemic reaching the levels of past deadly outbreaks like the 1894 plague and 1918-A(H1N1) influenza pandemic. The presence of multiple coronaviruses with pandemic potential in animals, coupled with environmental factors like the mixing and selling of wild mammals with poor hygiene practices in urban markets, pose a significant threat to global health. The emergence of new viruses and the challenges of mass testing, contact tracing, treatment, and potential development of vaccine-resistant virus variants highlight the importance of global preparedness in combating infectious diseases.
EMERGING MICROBES & INFECTIONS
(2021)
Review
Biotechnology & Applied Microbiology
Gaurav Joshi et al.
Summary: According to WHO, there are 117 COVID-19 vaccines in clinical development and 194 in preclinical development, with major platforms including protein subunit, RNA, and inactivated virus. Despite rapid manufacturing, the wealthiest countries holding only 10.8% of the world population have 28% of total vaccines, indicating an inequity in distribution.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2021)
Article
Biochemistry & Molecular Biology
Wanwisa Dejnirattisai et al.
Summary: Ending the SARS-CoV-2 pandemic requires global vaccination. New virus strains with mutations impact antibody responses, but some variants are less resistant than others. A monoclonal antibody can neutralize different variants and partially restore neutralization potency for other public antibodies.
Review
Microbiology
Seyed Hamid Safiabadi Tali et al.
Summary: This paper provides a comprehensive review of technologies and methods used for detecting SARS-CoV-2 during the COVID-19 pandemic, including molecular, antigen-based, and immunological point-of-care testing, diagnostic imaging techniques, and biomarkers. The importance of timing and type of specimen collection is emphasized, along with suggestions for future pandemic preparedness.
CLINICAL MICROBIOLOGY REVIEWS
(2021)
Review
Immunology
Lianlian Bian et al.
Summary: The global spread of the SARS-CoV-2 pandemic has led to the emergence of several variants, posing challenges to vaccine efficacy. However, some vaccines have shown advantages in providing protection against certain variants. Response strategies have been proposed to address the challenges posed by emerging variants, including accelerating the rollout of current vaccines, enhancing vaccine immunogenicity, and developing next-generation vaccines targeting the variants.
EXPERT REVIEW OF VACCINES
(2021)
Editorial Material
Medicine, General & Internal
Pere Domingo et al.
Article
Microbiology
Stephen Tahan et al.
Summary: Diagnostic assays for detecting SARS-CoV-2 are essential for patient management and infection prevention. Mutations can affect the accuracy of these assays, highlighting the importance of using dual-target assays to reduce false-negative results.
JOURNAL OF CLINICAL MICROBIOLOGY
(2021)
Review
Immunology
Sindhu Ramesh et al.
Summary: The widespread increase in SARS-CoV-2 variants is causing significant health concerns globally, with four variants of concern and several variants of interest identified for close monitoring. These variants exhibit increased transmissibility and severity, with significant impacts on the immune system.
Letter
Microbiology
Pedro E. Romero et al.
MICROBIOLOGY SPECTRUM
(2021)
Article
Infectious Diseases
Cristina Menni et al.
Summary: This study investigated the safety and effectiveness of the BNT162b2 and ChAdOx1 nCoV-19 vaccines in a UK community setting. The results showed that the frequencies of side effects from these vaccines were lower than reported in clinical trials, and a significant reduction in the risk of SARS-CoV-2 infection was observed starting at 12 days after vaccination.
LANCET INFECTIOUS DISEASES
(2021)
Letter
Medicine, General & Internal
Lindsay T. Keegan et al.
Review
Biochemistry & Molecular Biology
Ramesh Kandimalla et al.
Summary: The emergence of SARS-CoV-2 in late 2019 led to the COVID-19 pandemic, prompting rapid development of multiple vaccine candidates which have been commercialized in 2021. While these vaccines showed promising results, key insights into their epidemiology, protective mechanisms, and reinfection tendencies are lacking. This report provides insights into vaccination prospects, diverse strategies, approved vaccines, success rates, and potential challenges for the future.
Article
Multidisciplinary Sciences
Nicholas G. Davies et al.
Summary: Studies have shown that the SARS-CoV-2 B.1.1.7 lineage is more transmissible and may cause more severe illness compared to pre-existing variants.
Review
Microbiology
Saad Mallah et al.
Summary: COVID-19 is the second pandemic of the twenty-first century caused by a novel strain of coronavirus, primarily transmitted via respiratory droplets. The virus is characterized by the spike glycoprotein, and most patients experience flu-like symptoms, with common complications including pneumonia.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
(2021)
Editorial Material
Anesthesiology
Richard J. Lessells
ANAESTHESIA CRITICAL CARE & PAIN MEDICINE
(2021)
Article
Public, Environmental & Occupational Health
Lindsey Martin Webb et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2021)
Review
Microbiology
Ke-Yan Loo et al.
Summary: The fear of COVID-19 loomed over the global population as they welcomed the new year in 2021, with millions infected and lives at risk. Pharmaceutical companies swiftly developed various types of vaccines, with several already authorized for emergency use, while others await approval.
Review
Medicine, General & Internal
Bogdan Doroftei et al.
Summary: After analyzing 19 relevant articles, it was concluded that among the eleven vaccines, Pfizer-BioNTech (about 95%), Moderna (about 94%), and Sputnik V (about 92%) showed an efficacy greater than 90%, while Oxford-AstraZeneca was only about 81% effective. Additionally, Moderna, Sputnik V, and Oxford-AstraZeneca also reduced the occurrence of severe adverse reactions.
News Item
Medicine, General & Internal
Diana Duong
CANADIAN MEDICAL ASSOCIATION JOURNAL
(2021)
Review
Biochemistry & Molecular Biology
Sarah P. Otto et al.
Summary: After a year into the COVID-19 pandemic, attention has shifted to the emergence and spread of variants of concern (VOCs) of SARS-CoV-2. These variants have shown detrimental effects on virus transmission and severity, prompting global efforts to understand their impact on disease control and public health interventions. Efforts are being made to explore the evolutionary processes involved in the emergence of new variants and to minimize their impact on the ongoing pandemic.
Review
Pharmacology & Pharmacy
Vivek P. Chavda et al.
Summary: Intranasal vaccines have advantages in targeting SARS-CoV-2 infection, eliciting immune responses, and avoiding infections, while also convenient for self-administration and storage at ambient temperatures.
DRUG DISCOVERY TODAY
(2021)
Article
Infectious Diseases
Yaniv Lustig et al.
Summary: The study found that healthcare workers vaccinated with Comirnaty showed reduced neutralising titres against the Gamma, Beta, and Delta variants, but the remaining neutralisation capacity may still be protective.
Article
Infectious Diseases
Benedicte Roquebert et al.
Summary: During April to May 2021, variants of concern beta and gamma had a significant transmission advantage over variant alpha in Ile-de-France and Hauts-de-France regions in France, possibly due to their immune evasion abilities and high proportions of prior SARS-CoV-2-infected individuals in these areas.
Editorial Material
Medicine, General & Internal
Adam S. Lauring et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Editorial Material
Geriatrics & Gerontology
Vivek P. Chavda et al.
Article
Multidisciplinary Sciences
Dami A. Collier et al.
Summary: Elderly individuals, especially those above eighty, show lower immune responses and neutralization abilities against variants of concern after the first vaccine dose, but this improves after the second dose. They have higher frequencies of spike-specific memory B cells but reduced somatic hypermutation of class-switched cells. Production of interferon-gamma and interleukin-2 by SARS-CoV-2 spike-specific T cells is lower in older participants, predominantly by CD4 T cells.
Article
Multidisciplinary Sciences
Delphine Planas et al.
Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.
Article
Multidisciplinary Sciences
Jianying Liu et al.
Summary: Serum samples from individuals vaccinated with the BNT162b2 vaccine can neutralize various SARS-CoV-2 variants, indicating mass immunization as a central strategy to end the global COVID-19 pandemic.
Review
Microbiology
William T. Harvey et al.
Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.
NATURE REVIEWS MICROBIOLOGY
(2021)
Article
Multidisciplinary Sciences
Suman Pokhrel et al.
Summary: Two SARS-CoV-2 variants of concern have been identified recently, showing increased transmissibility compared to the Wuhan virus. While these variants do not appear to cause more severe illness or increased risk of death, the faster spread of the virus poses a major threat. Computational tools suggest that the increased transmissibility of the new variants may be due to changes in the spike protein structure, which could help in identifying potential treatments to combat these more transmittable strains.
Article
Multidisciplinary Sciences
Matthew McCallum et al.
Summary: The novel CAL.20C (B.1.427/B.1.429) variant carries spike protein mutations, resulting in reduced neutralizing titers in vaccinated individuals and convalescent individuals. The L452R mutation reduces neutralizing activity in RBD-specific monoclonal antibodies, while the S13I and W152C mutations lead to the total loss of neutralization in NTD-specific antibodies due to antigenic supersite remodeling.
Review
Virology
Anna Winger et al.
Summary: The high sequence identity of the initial SARS-CoV-2 samples collected in Wuhan in December 2019 did not predict the emergence of novel variants in different regions around the world. The viral spike receptor has two areas of high mutagenic plasticity, with mutations mainly focusing on the N-terminal domain and receptor binding domain. The evolution of spike mutations, including the characteristic D614G mutation, continues to drive the development of new variants.
Article
Multidisciplinary Sciences
Satoshi Ikegame et al.
Summary: The authors characterize the neutralizing capacity of post-Sputnik V vaccination sera against SARS-CoV-2 variants of concern B.1.1.7 (alpha) and B.1.351 (beta), showing the latter to exhibit resistance to neutralization in vitro.
NATURE COMMUNICATIONS
(2021)
News Item
Medicine, General & Internal
Gareth Iacobucci
BMJ-BRITISH MEDICAL JOURNAL
(2021)
Review
Biochemistry & Molecular Biology
Ayslan Castro Brant et al.
Summary: SARS-CoV-2 is a highly contagious respiratory virus causing adult atypical pneumonia COVID-19 with severe acute respiratory syndrome (SARS). This virus enters susceptible cells and directly translates polyproteins to initiate viral genome replication and transcription.
CELL AND BIOSCIENCE
(2021)
Article
Cell Biology
Bo Meng et al.
Summary: The Delta H69N70 mutation in SARS-CoV-2 spike protein increases infectivity and partially rescues immune escape mutations that impair infectivity. Continued surveillance and research on deletions with functional effects are necessary.
Review
Pharmacology & Pharmacy
Vivek P. P. Chavda et al.
Summary: Investigations into natural chemical compounds for their programmed necrosis potential have led to the emergence of multi-target drugs and new drug discovery methods like fragment-based drug discovery for natural anticancer agents.
FRONTIERS IN PHARMACOLOGY
(2021)
Editorial Material
Microbiology
Frank Konings et al.
Summary: A group convened and led by the Virus Evolution Working Group of the World Health Organization has announced a naming scheme to enable clear communication about SARS-CoV-2 variants of interest and concern.
NATURE MICROBIOLOGY
(2021)
Article
Immunology
Chiranjib Chakraborty et al.
Summary: This paper analyzed the Asian-origin COVID-19 vaccines and vaccination program status in Asia till March 2021 under three sections. The analysis includes the mapping of approved vaccines, evaluation of vaccination programs, and factors affecting the vaccination program, aiming to assist the successful implementation of COVID-19 vaccination program in Asia.
Article
Public, Environmental & Occupational Health
Emmanuelle Logette et al.
Summary: The research found that elevated blood glucose is a key factor in the progression of COVID-19 and can facilitate the disease through multiple mechanisms, explaining the differences in disease severity across populations. The study provides diagnostic considerations, new areas of research, and potential treatments, while also cautioning on the need for careful treatment strategies and critical care conditions that induce elevations in blood glucose levels.
FRONTIERS IN PUBLIC HEALTH
(2021)
Review
Medicine, General & Internal
Jun Yong Choi et al.
Summary: Since the beginning of the COVID-19 pandemic, the SARS-CoV-2 virus has evolved into various variants, with some designated as VOCs that have higher transmissibility and disease severity, potentially impacting vaccine effectiveness.
YONSEI MEDICAL JOURNAL
(2021)
Article
Medicine, Research & Experimental
Ralf Duerr et al.
Summary: The study found that breakthrough infections still occur after receiving COVID-19 mRNA vaccines, but the vaccines have high efficacy against B.1.1.7 and B.1.526 variants.
JOURNAL OF CLINICAL INVESTIGATION
(2021)
Review
Medicine, General & Internal
Elizabeth F. Peacocke et al.
Summary: This study aimed to identify factors affecting equitable access to COVID-19 vaccines for low and middle-income countries, finding four key factors such as collectively agreed global mechanisms, vaccine manufacturing, and countries' strength in implementing vaccination programs.
Review
Critical Care Medicine
Jasmin Khateeb et al.
Summary: Mutations in VOCs can increase the transmissibility of the virus and potentially impact vaccine efficacy, highlighting the need for combination therapeutic strategies.
Article
Immunology
Lishuang Shen et al.
Summary: The SARS-CoV-2 B.1.1.7 lineage, characterized by the N501Y mutation and other mutations, is highly infectious with high prevalence in Europe and the U.S. A sub-lineage of B.1.1.7 with M:V70L and S:D178H mutations emerged in the U.S., increasing in prevalence from February to April 2021. This sub-lineage, specific to the U.S., may have originated in California or Washington according to phylogenetic analysis.
EMERGING MICROBES & INFECTIONS
(2021)
Letter
Infectious Diseases
Sonia Jangra et al.
Review
Veterinary Sciences
Md Safiul Alam Bhuiyan et al.
Summary: IBV is a major economic problem in commercial chicken farms, despite vaccination efforts outbreaks continue due to inadequate vaccine candidates and emergence of novel variants. Improving diagnostic methods is essential to detect IBV infections, while various risk factors impact the effectiveness of IB vaccinations.
VETERINARY SCIENCES
(2021)
Editorial Material
Microbiology
Yi-Wei Tang et al.
JOURNAL OF CLINICAL MICROBIOLOGY
(2020)
Editorial Material
Biotechnology & Applied Microbiology
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY
(2020)
Article
Critical Care Medicine
Lisa K. Moores et al.
Article
Microbiology
Andrew Rambaut et al.
NATURE MICROBIOLOGY
(2020)
Article
Ethics
Jing-Bao Nie
JOURNAL OF BIOETHICAL INQUIRY
(2020)
Article
Ethics
Oghenowede Eyawo et al.
JOURNAL OF BIOETHICAL INQUIRY
(2020)
Article
Multidisciplinary Sciences
Jacob Kames et al.
SCIENTIFIC REPORTS
(2020)
Review
Immunology
Katie L. Flanagan et al.
FRONTIERS IN IMMUNOLOGY
(2020)
Review
Immunology
Sabrina Donati Zeppa et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2020)
Review
Ophthalmology
Rohit Shetty et al.
INDIAN JOURNAL OF OPHTHALMOLOGY
(2020)
Review
Biochemistry & Molecular Biology
Rafael Sanjuan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES
(2016)
Editorial Material
Immunology
Margaret Chan et al.
Review
Oncology
Damien Bregeon et al.
NATURE REVIEWS CANCER
(2011)
Article
Virology
AM Arvin et al.
